Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-26 @ 12:03 AM
Study NCT ID:
NCT00423592
Status:
COMPLETED
Last Update Posted:
2013-06-17
First Post:
2007-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2006-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-17
First Submit QC Date:
None
Study First Post Date:
2007-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-05-14
Results First Submit QC Date:
None
Results First Post Date:
2012-06-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-07
Last Update Post Date:
2013-06-17
Last Update Post Date Type:
ESTIMATED